Literature DB >> 8207822

Expression of a foreign protein by influenza A virus.

N Percy1, W S Barclay, A García-Sastre, P Palese.   

Abstract

In this report we describe the rescue of a transfectant influenza A virus which stably expresses a heterologous protein, bacterial chloramphenicol acetyltransferase (CAT). The foreign sequences encoding CAT are expressed as part of an essential influenza virus segment, that coding for the neuraminidase (NA) protein. The novel way by which this was achieved involved inserting in frame the 16-amino-acid self-cleaving 2A protease of foot-and-mouth disease virus between the CAT and the NA coding sequences. The resultant gene produces a polyprotein which is proteolytically cleaved to release both CAT and NA. The intramolecular cleavage occurs at the C terminus of the 2A sequence between a glycine-proline dipeptide motif such that the released NA protein has an additional N-terminal proline residue. The transfectant virus is stable upon passage in tissue culture. CAT activity is expressed at high levels in cell culture supernatants and in the allantoic fluid of infected eggs. Since the chimeric segment must maintain the heterologous reading frame to retain viability, the virus stability is dependent upon concomitant synthesis of the heterologous protein. This design may be particularly appropriate for utilization of influenza virus as a mammalian expression vector.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207822      PMCID: PMC236374     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  An improved method for sequencing double stranded plasmid DNA from minipreps using DMSO and modified template preparation.

Authors:  D Seto
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

2.  The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure.

Authors:  G X Luo; W Luytjes; M Enami; P Palese
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Amplification, expression, and packaging of foreign gene by influenza virus.

Authors:  W Luytjes; M Krystal; M Enami; J D Parvin; P Palese
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

Review 4.  Structural domains and organizational conformation involved in the sorting and transport of influenza virus transmembrane proteins.

Authors:  D P Nayak; M A Jabbar
Journal:  Annu Rev Microbiol       Date:  1989       Impact factor: 15.500

5.  The genes of influenza virus.

Authors:  P Palese
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

6.  High-efficiency formation of influenza virus transfectants.

Authors:  M Enami; P Palese
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Introduction of site-specific mutations into the genome of influenza virus.

Authors:  M Enami; W Luytjes; M Krystal; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.

Authors:  M D Ryan; A M King; G P Thomas
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

9.  Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes.

Authors:  S Q Li; J L Schulman; T Moran; C Bona; P Palese
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein.

Authors:  M D Ryan; J Drew
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  38 in total

1.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment.

Authors:  Feng Li; Liqiang Feng; Weiqi Pan; Zhenyuan Dong; Chufang Li; Caijun Sun; Ling Chen
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

5.  Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.

Authors:  Markus Wolschek; Elisabeth Samm; Helena Seper; Sanda Sturlan; Irina Kuznetsova; Cornelia Schwager; Alexandra Khassidov; Christian Kittel; Thomas Muster; Andrej Egorov; Michael Bergmann
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

6.  Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses.

Authors:  Jorge L Muñoz-Jordán; Maudry Laurent-Rolle; Joseph Ashour; Luis Martínez-Sobrido; Mundrigi Ashok; W Ian Lipkin; Adolfo García-Sastre
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 7.  Genetic engineering of animal RNA viruses.

Authors:  K K Conzelmann; G Meyers
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

8.  Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.

Authors:  Tokiko Watanabe; Shinji Watanabe; Takeshi Noda; Yutaka Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

Authors:  T Muster; B Ferko; A Klima; M Purtscher; A Trkola; P Schulz; A Grassauer; O G Engelhardt; A García-Sástre; P Palese
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Selective incorporation of influenza virus RNA segments into virions.

Authors:  Yutaka Fujii; Hideo Goto; Tokiko Watanabe; Tetsuya Yoshida; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.